Genetic Technologies Ltd ( GENE) - Stock Earnings
Stock symbol GENE is outdated, potentially delisted? Maybe it is available on other exchange?
GENE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -2.1 million USD | 1.8 million USD |
| 2023Q2 | -4.2 million USD | 3.0 million USD |
| 2023Q4 | -4.4 million USD | 2.7 million USD |
GENE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -5.4 million USD | 90394 USD |
| 2022 | -4.9 million USD | 4.7 million USD |
| 2023 | -7.8 million USD | 5.8 million USD |
GENE
Price: $0.76
52 week price:
Earnings Per Share: -0.15 USD
P/E Ratio: -14.82
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: Australia
Volume: 666231
Ebitda: -5.8 millionMarket Capitalization: 2.7 million